DUSTIN FROEHLICH: Open Payments
NPI 1457708794 · BRIGHTON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,116 in 101 payments from 17 companies in 2025. Trend: 2023 $1,904 · 2024 $1,783 · 2025 $2,116
Food & beverage: $2,116
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $455 |
| Axsome Therapeutics, Inc. | 7 | $226 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $201 |
| Vanda Pharmaceuticals Inc. | 11 | $200 |
| Otsuka America Pharmaceutical, Inc. | 11 | $197 |
| Tris Pharma Inc | 5 | $173 |
| Alkermes, Inc. | 7 | $152 |
| Collegium Pharmaceutical, Inc. | 5 | $88 |
| Corium, LLC | 5 | $86 |
| E.R. Squibb & Sons, L.L.C. | 4 | $81 |
Products named: VRAYLAR, Auvelity, CAPLYTA, FANAPT, REXULTI, Dyanavel XR, ARISTADA, Jornay PM.
Industry payments across CO — which companies pay providers there.
